IP Library Assignment 041379/0310
Patent Assignment
Reel/Frame 041379/0310

Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 040906 Frame: 0825. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2017-01-17 Pages: 9
Assignor
Assignee
NLS-1 PHARMA AG
BREITENWEG 10, STANS, CH-6370, SWITZERLAND
Covered Properties (3)
Mazindol Combination in the Treatment of Attention Deficit/Hyperactivity
Patent: 8,293,779 →
Application: 12/296,900 →
Publication: US 2009/0136593
Mazindol Combination in the Treatment of Attention Deficit/Hyperactivity
Application: 13/590,459 →
Publication: US 2012/0308668
Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity
Application: 14/884,204 →
Publication: US 2016/0030394
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 7, 2009
From: KONOFAL, ERIC
To: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Reel/Frame 022221/0942 →
Assignment of Assignor's Interest Oct 5, 2012
From: KONOFAL, ERIC
To: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
Reel/Frame 029082/0212 →
Assignment of Assignor's Interest Feb 8, 2016
From: KONOFAL, ERIC
To: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Reel/Frame 037683/0004 →
Assignment of Assignor's Interest Nov 16, 2016
From: L'ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
To: NLS-1 PHARMA AG
Reel/Frame 040906/0825 →
Change of Name Sep 12, 2019
From: NLS-1 PHARMA AG
To: NLS PHARMACEUTICS AG
Reel/Frame 050352/0339 →